Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market
February 06, 2023 09:02 ET
|
Sharps Technology Inc
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market
February 01, 2023 09:20 ET
|
Sharps Technology Inc
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
January 31, 2023 08:00 ET
|
Sharps Technology Inc
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be...
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023
January 10, 2023 08:00 ET
|
Sharps Technology Inc
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market...
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products
December 20, 2022 08:00 ET
|
Sharps Technology Inc
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently...
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products
December 13, 2022 08:00 ET
|
Sharps Technology Inc
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between Sharps...
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
November 10, 2022 16:05 ET
|
Sharps Technology Inc
WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative...
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
July 14, 2022 16:05 ET
|
Sharps Technology Inc
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use...
Sharps Technology Announces Letter to Shareholders
June 08, 2022 16:05 ET
|
Sharps Technology Inc
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented, best-in-class, single use...
Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering
April 19, 2022 09:50 ET
|
Sharps Technology Inc
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use...